Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
**Approach:** Conceptual metaphor. **Palette:** Bold color field (teal). A single flexible garden hose, shot from a low three-quarter angle, lies coiled against a saturated teal seamless backdrop. One half of the hose is pale and wrinkled, with a stiff, cracked rubber texture and a visible kink. The other half is supple, glossy and smoothly curved. A thin stream of water arcs from the open end, catching the light. Soft, large-source studio light comes from the upper left and casts gentle, neutral grey shadows with no blue cast. A small electric green brass fitting, with a clean metallic sheen, sits where the two halves meet. The shallow depth of field blurs the coils in the foreground. The mood is quietly doubtful but curious, as if the result is promising and still unproven. There is no text anywhere in the frame.
Longevity

Magnesium Ngeredam Kekakuan Arteri Sawisé 6 Wulan—Nanging Ana Uji Null

Dr. Synapse · · 4 min read
#longevity #arterial stiffness #magnesium #cardiovascular health #randomized trial #vascular aging #pulse wave velocity

Magnesium Ngeredam Kekakuan Arteri Sawisé 6 Wulan—Nanging Ana Uji Null

Ringkesan: Sajeroning 12 minggu, magnesium ora nambah apa‑apa sing kawruh babagan kekakuan arteri. Ing minggu kaping‑24, uji coba acak 52 wong nemokake kecepatan gelombang nadi mundhak 1,0 m/s dibandhingake placebo, tanpa owah‑owahan tekanan darah. Iki asil sing narik kawigaten kanggo sapa wae sing kepengin mangerteni penuaan vaskular. Nanging, pamulangan sing luwih gedhe ing 2022 saka tim sing padha, sing nyoba 164 wong lan telung bentuk magnesium, ora nemokake efek signifikan. Kene dhèskripsi saka studi asli, kelemahane, lan apa sing kudu dipikirake saka bukti sing kontradiktif.

Telung minggu ing tengah trial, klompok magnesium ora nuduhake bedane apa‑apa karo klompok placebo. Banjur para peneliti ngetung maneh ing minggu kaping‑24, lan gambaré malih. Keterlambatan iki dadi titik paling menarik saka uji coba 2016 babagan magnesium lan kekakuan arteri, sing dadi proksi carane cepet pembuluh getihmu nambah umur. Uji coba sing luwih gedhe lan anyar saka grup peneliti sing padha malah ngambahake korek iki dadi luwih rumit.

Studi: Cilik, Terkontrol, Lan Blind Secara Teliti

Tulisan iki, diterbitaké ing American Journal of Clinical Nutrition dening Joris lan kancané saka Maastricht University, yaiku uji coba acak, double‑blind, lan placebo‑controlled suwene 24 minggu. Nggoleki 52 wong diwasa sing agak overweight utawa rada obes, kalebu 30 priya lan 22 wanita pascamenopause, karo umur rata‑rata 62 ± 6 taun.

Peserta ngonsumsi kapsul magnesium utawa placebo telung kaping saben dina. Klompok magnesium nampa 3 × 117 mg, kira‑kira 350 mg saben dina. Abstrak ora nyebutaké senyawa magnesium sing dipigunakaké, mula ora bisa dipastikan apa wujudé.

Ukuran vaskular utama yaiku carotid‑to‑femoral pulse wave velocity (PWVc‑f), diukur ing wiwitan, minggu 12, lan minggu 24. Iki cara umum kanggo ngétung kekakuan arteri. Gelombang nadi sing luwih cepet nuduhaké arteri sing luwih kaku, lan kekakuan iki cenderung mundhak bareng umur. Tim uga nglumpukaké urin 24 jam lan ngrekam tekanan darah ambulatory 24 jam ing wiwitan lan pungkasan.

Asil Sing Mencorong: Penurunan 1,0 m/s, Nanging Mung Ing Minggu Kaping‑24

Nomer utama sing dibahas:

  • Minggu 12: Bedane PWVc‑f dibandhingake placebo 0,0 m/s (95 % CI ‑0,6 nganti 0,5; p = 0,90). Ora ana efek.
  • Minggu 24: PWVc‑f mudhun 1,0 m/s ing klompok magnesium dibandhingake placebo (95 % CI 0,4 nganti 1,6; p = 0,001).

Mula, manfaaté ora metu nggantheng. Pengaruh magnesium marang dinding pembuluh ora ketok nganti tengah trial. Iki cocok karo gagasan manawa kekakuan vaskular nglambangaké owah‑owahan struktural lan fungsional sing alon, dudu perkara sing bisa diganti mung sajrone sawetara minggu. Studi iki ora bisa nerangaké kenapa efeké muncul mengko, lan penulis negesaké temuan iki minangka hipotesis potensial tinimbang bukti pasti.

Apa Sing Ora Owah (Lan Kenapa Kuwi Penting)

Ana loro rincian penting sing kudu digatekaké.

Tekanan darah tetep stabil. Baik tekanan darah ing klinik maupun ambulatory 24 jam ora owah. Yèn magnesium memang ngeredam kekakuan arteri, kedadené ora mesthi ngurangi tekanan darah kaya sing akèh wong ngarep‑arep. Iki menarik, nanging uga nuduhaké asil iki ora mung cerita “tekanan darah mudhun”.

Serum magnesium mung sethithik mundhak. Tingkat magnesium ing getih mung nambah cilik ing minggu kaping‑24 (+0,02 mmol/L; 95 % CI 0,00 nganti 0,04; p = 0,09), ora cukup signifikan. Ekskresi magnesium ing urin mundhak 2,01 mmol per 24 jam (p < 0,001), mbuktèkaké peserta pancen njupuk kapsul lan nyerep mineral kasebut. Serum magnesium diatur kanthi ketat lan ora dadi kaca jendela sing akurat menyang total cadangan awak, mula iki lumrah, nanging dadi alesan kenapa kita ora bisa ngubungaké efek vaskular karo perubahan kadar getih sing jelas.

Ora ana kejadian adverse sing dilaporaké.

Plot Twist: Uji Coba Gedhé Ora Nemokake Apa‑apa

Yèn critane mandheg ing kéné, mesthi dadi “hook” longevity sing nggegirisi. Nanging ora. Pamulangan sing luwih gedhe saka grup sing padha (Schutten, Joris et al., 2022, Journal of the American Heart Association, PMID 35253448) melu 164 wong diwasa sing agak overweight utawa rada obes. Dibandhingake magnesium citrate, oxide, lan sulfate kanthi dosis 450 mg saben dina karo placebo kanggo 24 minggu. Ora ana efek signifikan marang kekakuan arteri utawa tekanan darah.

Loro trial iki beda dosis, formulasi, lan ukuran sampel, mula ora bisa dibandhingaké kanthi tepat. Nanging pamulangan sing luwih gedhe lan nguji macem‑macem bentuk magnesium ora ngulang asil 2016. Makna adilé yaiku asil asli kudu dianggep sinyal sing ngasilake hipotesa, dudu bukti manfaat sing wis dipesthèkaké.

Watesan sing Pantes Diketahui

  • Sampel cilik: 52 wong iku modest, lan trial cilik bisa ngluwihi perkiraan efek.
  • Populasi spesifik: Dewasa sing agak overweight utawa rada obes umur kira‑kira 62 taun. Hasilé bisa ora bisa ditrapaké kanggo wong kurus, luwih enom, utawa sing wis sehat.
  • End‑point surrogate: PWV iku marker sing gegandhengan karo risiko kardiovaskular, ora ukuran serangan jantung, stroke, utawa umur panjang. Trial iki ora dirancang kanggo nuduhaké asil klinis nyata.
  • Ora direplikasi: Pamulangan sing luwih gedhe ora konfirmasi efek kasebut.
  • Bentuk magnesium ora jelas: Abstrak ora nyebutaké senyawa magnesium sing dipigunakaké.

Takeaway Praktis

Apa sing diuji: Kira‑kira 350 mg magnesium saben dina, dipérang dadi telung dosis kira‑kira 117 mg, nganti 24 minggu. Manfaat apa wae, yen nyata, butuh wektu enem wulan kanggo muncul, mula eksperimen sing cendhak ora bakal menehi informasi sing cukup.

Sapa sing bisa minat: Dewasa umur 50‑60 taun sing agak overweight lan kepengin ndhukung kesehatan vaskular. Nanging, bukti iki campur‑aduk, lan magnesium ora dadi gantine pendekatan terbukti kaya olahraga, ngatur bobot badan, ngontrol tekanan darah, lan diet sing sugih panganan magnesium kaya kacang polong, kacang‑kacangan, wiji‑wijian, lan sayuran ijo.

Sapa sing kudu ati‑ati utawa ngindari: Iki mung pandhuan umum, dudu temuan definitive. Ginjal ngilangi magnesium sing kakehan, mula wong sing duwe penyakit ginjal ora kena suplemen tanpa pangawasan medis. Sapa waé sing nggunakake obat resep, utamané kanggo kondisi jantung, kuduné konsultasi dhisik karo dokter utawa apoteker. Dosis magnesium tambahan kerap nyebabaké gangguan pencernaan, lan 350 mg saben dina uga wates maksimal sing disaranaké kanggo suplemen magnesium ing wong diwasa ing AS.

Kesimpulan: Trial cilik sing dilakokaké kanthi becik ndelok arteri sing kaku dadi luwih lentur sawisé enem wulan suplemen magnesium, tanpa perubahan tekanan darah lan tanpa kejadian adverse. Pamulangan sing luwih gedhe ora nemokake efek sing padha. Anggep magnesium minangka piranti sing menarik nanging durung dibuktikaké kanggo nglawan penuaan vaskular, dudu solusi sing pasti.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Macro photograph at a low 30-degree angle of two tiny mounds on a glossy, saturated teal acrylic surface. The left mound is orange-yellow CoQ10 crystalline powder with visible faceted flakes. The right mound is dull metallic grey selenium granules. A hairline crack runs across the acrylic between them, hinting at the catch. Hard, clean studio light from the upper left throws crisp, short shadows and sparkles on the crystal edges. The background falls softly out of focus, with a thin electric green reflection streaking across the glossy surface. The palette is bold color field: teal against orange, with silver-grey accents. The mood is precise, curious and cautionary, like a lab specimen photographed for a magazine. Photorealistic, shallow depth of field, no text.
longevity

Loro Suplemen Murah Sing Ngurangi Kematian Jantung nganti Setengah: Ana Pengecualian

BY NOVA CHEN ·

Loro suplemen regane terjangkau, CoQ10 lan selenium, kacemplungake karo penurunan kematian kardiovaskular saka 12,6 % dadi 5,9 % ing warga senior Swedia. Biomarker stres jantung lan ekokardiogram uga nuduhaké perbaikan. Nanging panalitèn iki mung ndarbeni 443 wong saka negara sing seleniumé kurang, lan ora bisa nemtokaké suplemen endi sing dadi penyebab utama. Artikel iki nerangaké apa sing sejatine dituduhaké studi KiSel‑10, sapa sing bisa entuk manfaat, lan wates keamanan sing kudu dipahami sadurunge nyoba.
A bright, minimalist editorial still life on a pale warm-white stone surface, shot from a slightly elevated three-quarter angle in soft natural window light. At center, a small amber glass supplement bottle with a matte cream label, unbranded, sits beside a few loose white capsules. A pair of weathered hands in a light oatmeal linen sleeve, belonging to an older adult, rests gently near the bottle, with a ceramic mug of tea just out of focus. To the right, a clean glass vial and a delicate glass beaker filled with clear liquid catch the light, hinting at laboratory research without any futuristic touch. A small paper notebook with a handwritten simple line graph rising in a gentle curve lies open nearby, along with a sharpened pencil. Scattered at the edges are soft sprigs of dried eucalyptus and a few pale sage-green leaves, adding an organic note. A faint, abstract molecular diagram printed in muted teal ink on a card leans against the bottle, subtle and graphic. The palette is calm and modern: warm ivory, sage green, soft teal, muted amber, and touches of dusty peach. Long, gentle shadows fall across the surface, and the shallow depth of field blurs the background into creamy neutral tones. The composition leaves generous negative space on the left third for headline text. The overall feel is a trendy health and science journal: clean, airy, trustworthy, and quietly sophisticated, with fine film-like grain and true-to-life color. Ultra-detailed, 16:9 landscape.
supplements

1.000 mg Nicotinamide Riboside saben dina nambah NAD+ ing sel getih kira‑kira 60 % ing wong diwasa tuwa, asil uji coba acak

BY DR. SYNAPSE ·

Uji coba crossover ing *Nature Communications* taun 2018 nyoba Nicotinamide Riboside (NR) 500 mg kaping loro saben dina (total 1.000 mg) nganti enem minggu marang wong diwasa sehat umur setengah umur nganti pra‑tua. Suplemen iki ditampa kanthi apik lan nambah NAD+ ing sel imun getih kira‑kira 60 % tinimbang plasebo. Peneliti uga nyatet sinyal wiwitan babagan tekanan darah sing luwih murah lan kekakuan arteri, nanging iki mung gagasan kanggo uji coba gedhé, ora bukti manfaat sing pasti. Artikel iki nerangake kenapa NAD+ dipikir turun bareng umur, apa sing ditindakake studi, lan apa sing ora bisa diceritakake babagan hasil penyakit utawa umur panjang.
Approach 4, conceptual metaphor, in palette D, bold color field. A single old brass pocket watch, photographed from a slightly high three-quarter angle, sits on a saturated mustard-yellow seamless backdrop. The watch case is cracked open and its glass is gone. One half of the gear train is clean and polished. The other half is corroded, with a dull green-black patina. A few fine droplets of clear liquid sit on the corroded gears, and one tiny electric green (#00e676) glint of oxidation shows at the edge of the damage. Hard but slightly diffused studio strobe from the upper left casts a crisp, short shadow on the yellow. The macro lens gives a shallow depth of field, with the sharpest focus on the split between healthy and damaged gears. The mood is cautionary, precise and quietly unsettling. No text or numerals appear on the dial.
longevity

Komponen Anti‑Aging Spermidine Duwe Efek Peteng ing Sel T Lawas

BY DR. SYNAPSE ·

Spermidine akeh dipromosikaké minangka poliamin anti‑penuaan, nanging panalitèn sel tikus anyar nemokaké yèn senyawa iki bisa ngganggu klompok sel imun lawas tartamtu. Ing sel CD49d‑ CD8+ sing mirip senesens, spermidine nyuda pernapasan mitokondria, ngilangi cadangan anti‑oksidan, lan ngowahi struktur mitokondria dadi pecah‑pecah. Sel tetanggan CD49d+ ora kena pengaruh. Sel saka tikus enom nanggapi kanthi cara sing beda, dadi umur dadi variabel penting. Iki kerja laboratorium, dudu bukti kerusakan ing manungsa, nanging nentang anggapan yèn spermidine migunani kanggo saben sel sing menua.
Approach: conceptual metaphor. Palette: D, bold color field. Subject: a single old-fashioned mechanical light switch, photographed straight on, with its toggle stuck halfway between on and off. It is mounted on a saturated mustard-yellow painted wall. A thin electric green (#00e676) glow leaks from the gap behind the toggle and casts a small green rim onto the plate. Beside it, a row of six small matte black tally marks is scratched into the paint, with the third and fifth marks fainter and partly worn, hinting at inconsistent results across days. Camera: slightly low, eye-level angle with a 50mm lens, shallow depth of field, and the switch placed on the right third of the frame. Lighting: hard directional side light from the left casts crisp, warm-neutral shadows with no blue cast. The wall texture and brushstrokes are visible. Mood: curious, skeptical, and measured. The scene suggests a mechanism that is partly engaged.
longevity

Diet Mirip Puasa Ngedongkrak Autophagy Manungsa—Nanging Ora Saben Wektu

BY HELIX WARD ·

Apa diet mirip puasa (FMD) pancen isa ngaktifake proses pembersihan sel dhewe, utawa mung fenomena ing tikus? Sawijining uji coba acak pilot sing melu 30 relawan sehat ngetes ProLon lan FMD2 dibandhingake karo grup kontrol. Sawisé kira‑kira enem dina, loro grup nuduhaké owah‑owahan ing aliran autophagy, bobot awak, glukosa, keton, lan resistensi insulin. Nanging perbedaan kuwi ora konsisten ing saben wektu, lan uji coba cilik iki disponsori dening produsen ProLon. Kene carane protokol ditindakake, apa asil sing ditemokaké, lan sapa sing kudu mikir kaping pindho sadurunge nyoba.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文